Related Experiment Video
Updated: Jun 16, 2026

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
Published on: October 4, 2019
Conocarpan and Eupomatenoid-6 as Natural Prototypes for Antituberculosis Compounds
Lincoln Luís Silva1, Anderson Valdiney Gomes Ramos2, Debora Cristina Baldoqui2
1Department of Pharmacy, State University of Midwest Paraná, Guarapuava, Brazil.
Two neolignans from Piper solmsianum show promise for treating drug-resistant tuberculosis (TB). Conocarpan (1) demonstrated synergistic effects with rifampicin, indicating potential for TB and TB/HIV coinfection therapies.
Area of Science:
- Natural Product Chemistry
- Microbiology
- Pharmacology
Background:
- Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a leading infectious disease.
- The rise of multidrug-resistant TB (MDR-TB) necessitates novel therapeutic agents.
- Piper solmsianum yielded two neolignans, conocarpan (1) and eupomatenoid-6 (2), for investigation.
Purpose of the Study:
- To evaluate the in vitro activity of conocarpan (1) and eupomatenoid-6 (2) against drug-susceptible and MDR-TB isolates.
- To assess the cytotoxicity of these neolignans in mammalian cell lines.
- To investigate the potential synergistic or antagonistic interactions with existing anti-TB and antiretroviral drugs.
Main Methods:
- Neolignans were isolated using high-performance liquid chromatography.
- In vitro activity was determined via resazurin microtiter assays against Mtb strains and other bacteria.
- Cytotoxicity was evaluated using MTT assays in various cell lines (J774.A1, HeLa, VERO, MRC-5).
- Drug combination assays assessed synergistic and antagonistic effects.
- ADME properties were predicted using Swiss ADME.
Main Results:
- Both compounds (1) and (2) exhibited activity against Mtb, Mycobacterium abscessus, and Staphylococcus aureus (MICs 3.90–125 μg/mL).
- Conocarpan (1) showed synergism with rifampicin; no antagonistic effects were observed with other drugs.
- Compounds displayed selectivity for bacteria over mammalian cells, with eupomatenoid-6 (2) being the least cytotoxic.
- Predicted ADME properties indicated high gastrointestinal permeability and compliance with Lipinski's rules.
Conclusions:
- Conocarpan (1) and eupomatenoid-6 (2) possess significant antibacterial activity.
- The synergistic interaction of conocarpan (1) with rifampicin highlights its potential for treating drug-resistant TB.
- These neolignans are promising candidates for further development, particularly for TB/HIV coinfection management.
Related Concept Videos
Antifungal Agents
Five-Membered Heterocyclic Aromatic Compounds: Overview
Bacterial Phylum Actinobacteria
Anthelminthic Agents
Aromatic Compounds: Overview
In 1825, Faraday isolated benzene...
Criteria for Aromaticity and the Hückel 4n + 2 Rule
For the first time, Eric Hückel, a German chemical physicist, derived a set of structural features for a compound to be classified as aromatic. This is now known as Hückel’s rule or the 4n + 2 rule.
